Top compounds associated with response to NOL4L


Feature Type Standardized
Nominal ANOVA
mRNA ML311 CTRPv2 pan-cancer AAC -0.078 0.02
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.084 0.02
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.088 0.02
mRNA JNK-9L GDSC1000 pan-cancer AAC -0.083 0.02
mRNA oligomycin a CTRPv2 pan-cancer AAC -0.086 0.02
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.02
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.02
mRNA MK-2206 CTRPv2 pan-cancer AAC -0.085 0.02
mRNA KPT185 CTRPv2 pan-cancer AAC -0.09 0.02
mRNA FH535 GDSC1000 pan-cancer AAC -0.08 0.02
Download CSV